INDUSTRY SYMPOSIUM // UCB - The contribution of real-life data in the perception of autoimmune myasthenia gravis

25 April 2024

SYMPO

• SYMPO7 • 12:00 > 13:00 • INDUSTRY SYMPOSIUM // UCB - The contribution of real-life data in the perception of autoimmune myasthenia gravis • 352 A+B

• SYMP7L1 • Welcome and introduction • SYMP7L2 • What contributions does the SNDS make towards the definition of different populations of autoimmune myasthenia gravis? > C. Céline TARD (Lille, France) • SYMP7L3 • MyastheniaGravis, its Impact on QOL and Work in France (SPOON Study) : an innovative methodology to qualify patient needs. > M. Matthieu LUSIGNAN (Bordeaux, France)